chevron_leftBack
As of 7 June 2026, China National Medicines Corporation Ltd. has a market cap of $3.19B USD, ranking #5200 globally and #1101 in China.
It ranks #407 in the Healthcare sector, and #160 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$3.19BUSD
21.62B CNY
Enterprise Value
$2.38BUSD
16.1B CNY
Revenue (TTM)
$7.88BUSD
53.31B CNY
EBITDA (TTM)
$319.98MUSD
2.17B CNY
Net Income (TTM)
$297.19MUSD
2.01B CNY
EBITDA Margin
4.1%
Profit Margin
3.8%
PE Ratio
10.7
Forward PE
10.3
PS Ratio
0.4
PB Ratio
1.0
EV/EBITDA
7.1
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yuetao Liu
open_in_new
Employees
3,024
Founded
1999
Website
cncm.com.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.2% | 1.2% | -0.7% | -2% | -3.2% | -0.6% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
600511
国药集团药业股份有限公司 Class A
ISIN: CNE000001D56
Shares Out.:
Shares Outstanding:
754.503M1
Shares Float:
754.249M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
28.66 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About China National Medicines Corporation Ltd.
China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental drug and equipment, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. operates as a subsidiary of Sinopharm Group Co. Ltd.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.9B
2K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.69B
1K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
793%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
489%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.53B
417%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
401%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
24K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
17K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
11K%
|
97.4
|
|
SIX: RO
|
$324.68B
10K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.43B
9K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$277.35B
9K%
218.9B CHF
|
20.5
|
chevron_leftBack